Alyeska Investment Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-85,696
| Closed | -$1.58M | – | 486 |
|
|
2024
Q1 | $1.58M | Sell |
85,696
-499,340
| -85% | -$9.23M | 0.01% | 376 |
|
|
2023
Q4 | $18.3M | Buy |
585,036
+185,036
| +46% | +$5.79M | 0.12% | 211 |
|
|
2023
Q3 | $8.34M | Buy |
+400,000
| New | +$8.34M | 0.06% | 301 |
|
|
2019
Q1 | – | Sell |
-175,000
| Closed | -$2.83M | – | 319 |
|
|
2018
Q4 | $2.83M | Buy |
+175,000
| New | +$2.83M | 0.04% | 246 |
|
|
2018
Q2 | – | Sell |
-614,166
| Closed | -$13.8M | – | 404 |
|
|
2018
Q1 | $13.8M | Sell |
614,166
-41,336
| -6% | -$929K | 0.11% | 185 |
|
|
2017
Q4 | $19.7M | Buy |
655,502
+289,583
| +79% | +$8.72M | 0.16% | 150 |
|
|
2017
Q3 | $13.8M | Sell |
365,919
-80,511
| -18% | -$3.03M | 0.1% | 205 |
|
|
2017
Q2 | $12.5M | Buy |
446,430
+73,593
| +20% | +$2.05M | 0.1% | 214 |
|
|
2017
Q1 | $12.8M | Buy |
+372,837
| New | +$12.8M | 0.1% | 232 |
|